Healthcare / Medical Care FacilitiesWarsaw
$19.00
-0.10 (-0.52%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 27% · confianza 25%
FCF escenarios
weak_data · normalized FCF $55.2M · quality 46.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$537M
P/E
70.4x
↑EV/EBITDA
7.8x
↓ROE
6.9%
↑Gross Margin
9.3%
↓Debt/Equity
1.84
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+20.0%
FCF CAGR
—
FCF margin
3.7%
FCF / Net income
2.48x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $854.3M · net income $12.9M · FCF $32.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $854.3M | $854.3M | $735.6M | $616.8M | $494.9M |
| Net Income | $12.9M | $12.9M | $14.6M | $7.9M | $-23.6M |
| EBITDA | $108.1M | $108.1M | $105.0M | $91.0M | $40.0M |
| EPS | 0.46 | 0.46 | 0.52 | 0.28 | -0.83 |
| Gross Margin | 9.3% | 9.3% | 8.0% | 4.4% | 2.2% |
| Operating Margin | 2.5% | 2.5% | 3.1% | 0.5% | -4.1% |
| Net Margin | 1.5% | 1.5% | 2.0% | 1.3% | -4.8% |
| Balance Sheet | |||||
| Debt/Equity | 1.84 | 1.84 | 1.59 | 1.70 | 1.43 |
| Current Ratio | 0.60 | 0.60 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $32.0M | $32.0M | $58.3M | $55.2M | $-5.9M |
| Returns | |||||
| ROE | 6.9% | 6.9% | 8.5% | 5.0% | -15.5% |
| Valuation | |||||
| P/E | 70.37 | 70.37 | 38.46 | 67.86 | — |
| EV/EBITDA | 7.82 | 7.82 | 7.65 | 8.57 | 15.47 |
| P/B | 2.89 | 2.89 | 3.27 | 3.40 | 2.79 |
| Growth & Yield | |||||
| Revenue Growth | 16.1% | 16.1% | 19.3% | 24.6% | — |
| EPS Growth | -11.5% | -11.5% | 85.7% | 133.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
54.2%
EPS terminal req.
$1.69
Spread vs growth
-65.7%
5Y implied EPS CAGR
34.7%
EPS terminal req.
$2.04
Spread vs growth
-46.2%
10Y implied EPS CAGR
21.7%
EPS terminal req.
$3.29
Spread vs growth
-33.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-4.0%
Start / end P/E
38.3x → 41.5x
EPS bridge
0.52 → 0.46
Residual
-1.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.